Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase 2 2

Status

Recruiting 5Terminated 1

Sponsor Class

INDUSTRY 6

Study Type

Interventional 6

Sponsor

Cancer Type

Other solid neoplasm 6Thoracic 5Gastrointestinal 5Head & Neck 2Genitourinary 1Dermatologic 1

Conditions

Advanced Solid Tumour 2Advanced Solid Tumor 2Solid Tumor 1Advanced Solid Tumors 1

Interventions

pembrolizumab 15Injections 13Pemetrexed 8Carboplatin 8tislelizumab 6Interviews as Topic 6Standard of Care 5Specimen Handling 5Practice Guidelines as Topic 5Fluorouracil 5Cisplatin 5Bevacizumab 5atezolizumab 4Oxaliplatin 4Docetaxel 4sotorasib 3fludarabine 3Paclitaxel 3Nivolumab 3Methods 3Leucovorin 3Irinotecan 3Educational Status 3Early Intervention, Educational 3Capecitabine 3toripalimab 2Radiotherapy, Intensity-Modulated 2Patient Navigation 2Magnetic Resonance Spectroscopy 2Gemcitabine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
tislelizumab × Other solid neoplasm × 30 days × Clear all
NCT07414836 2026-05-27

A First-in-Human Study of BG-C0979 in Adults With Advanced Solid Tumors

BeOne Medicines

Phase 1 Recruiting
84 enrolled
Other solid neoplasm

Advanced Solid Tumor

NCT06596473 2026-05-26

A Study of BG-C477 in Participants With Advanced Solid Tumors

BeOne Medicines

Phase 1 Recruiting
310 enrolled
Other solid neoplasm

Advanced Solid Tumors

NCT05981703 2026-05-22

A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors

BeOne Medicines

Phase 1 Recruiting
217 enrolled
Other solid neoplasm

Advanced Solid Tumor

NCT07331155 2026-05-18

A Phase II Clinical Study of LBL-024 Combination Therapy in Patients With Advanced Solid Tumour[Substudy 03(ESCC)]

Nanjing Leads Biolabs Co.,Ltd

Phase 2 Recruiting
110 enrolled
Other solid neoplasm

Advanced Solid Tumour

NCT07390383 2026-05-13

A Phase II Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumour[Substudy 04]

Nanjing Leads Biolabs Co.,Ltd

Phase 2 Recruiting
110 enrolled
Other solid neoplasm

Advanced Solid Tumour

NCT06487858 2026-05-11

A Study of BGB-R046 as Monotherapy and in Combination With Tislelizumab in Solid Tumors

BeOne Medicines

Phase 1 Terminated
42 enrolled
Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡